Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 1 - 10 of 81

U.S. Overdose Deaths Remain Higher Than in Other Countries — Trend-Tracking and Harm-Reduction Policies Could Help

This blog post reviews the rate of overdose fatality in the United States and how it compares to that of other countries. The blog post also reviews harm reduction policies that could assuage this crisis.
Format
Web Page
Audience
Policymakers and Payers
States
Graduate Education
Source
The Commonwealth Fund
Year
Resource Type
Web Page

2021-2022 Older Adult Behavioral Health

This report, based on findings from the 2021 and 2022 National Surveys on Drug Use and Health (NSDUH) presents key substance use, mental health, and treatment indicators among adults aged 60 or older in the United States.
Format
Report/Paper/Issue Brief
Audience
Behavioral Health Providers
Families
Communities
Policymakers and Payers
States
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF

Drug Overdose Death Rates

This web page highlights statistics on deaths involving drugs commonly associated with fatal overdose from 1999-2022 collected by the National Center for Health Statistics (NCHS) at the Centers for Disease Control and Prevention.
Format
Web Page
Audience
Behavioral Health Providers
Communities
Policymakers and Payers
States
Source
National Institute on Drug Abuse (NIDA)
Year
Resource Type
Web Page

FDA recommends changes to labeling for transmucosal buprenorphine products indicated to treat opioid use disorder

This press release details the FDA's recommended changes to labeling transmucosal buprenorphine products for opioid use disorder treatment. These recommendations are motivated by concerns about misinterpretation about current labeling strategies.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Source
U.S. Food & Drug Administration (FDA)
Year
Resource Type
Web Page

National Survey on Drug Use and Health (NSDUH) 2022 Highlighted Population Slides

These slides focus on substance use and mental health measures for several sub-populations in the United States, including American Indian and Alaska Native; Asian; Black or African; Female; Hispanic or Latino; Lesbian, Gay, or Bisexual Adult; Multiracial; Native Hawaiian and Other Pacific Islander; and Veteran populations.
Format
Other
Audience
Behavioral Health Providers
Communities
Policymakers and Payers
States
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF

Opioid Stewardship Hub

The resources on this webpage include ideas, insights, and resources to inspire opioid stewardship, and illustrate how hospitals and health systems are working to “Stem the Tide” of the opioid epidemic.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
American Hospital Association (AHA)
Year
Resource Type
Web Page

The Legal Landscape for Opioid Treatment Agreements

This article surveyed laws and regulations in all 50 states and the District of Columbia, as well as criminal and civil judicial decisions in which opioid treatment agreements were discussed as evidence, finding minimal evidence that they effectively reduce opioid misuse or improve patient outcomes.
Format
Report/Paper/Issue Brief
Audience
Policymakers and Payers
States
Source
The Milbank Quarterly
Year
Resource Type
Article

988 Partner Toolkit

This web page is a resource center for social media, video, print, radio, FAQs, messaging, and other marketing materials that can be used to promote the 988 Suicide & Crisis Lifeline. It is designed for states, territories, tribes, crisis centers, communities, emergency service providers, and other partners to speak with one voice.
Format
Toolkit
Audience
States
Communities
Other Team Members
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
Web Page